rs34343511

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_014321.4(ORC6):​c.675T>C​(p.Asp225Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0236 in 1,613,482 control chromosomes in the GnomAD database, including 565 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 45 hom., cov: 33)
Exomes 𝑓: 0.024 ( 520 hom. )

Consequence

ORC6
NM_014321.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0550

Publications

9 publications found
Variant links:
Genes affected
ORC6 (HGNC:17151): (origin recognition complex subunit 6) The origin recognition complex (ORC) is a highly conserved six subunit protein complex essential for the initiation of the DNA replication in eukaryotic cells. Studies in yeast demonstrated that ORC binds specifically to origins of replication and serves as a platform for the assembly of additional initiation factors such as Cdc6 and Mcm proteins. The protein encoded by this gene is a subunit of the ORC complex. Gene silencing studies with small interfering RNA demonstrated that this protein plays an essential role in coordinating chromosome replication and segregation with cytokinesis. [provided by RefSeq, Oct 2010]
ORC6 Gene-Disease associations (from GenCC):
  • Meier-Gorlin syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Meier-Gorlin syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 16-46697501-T-C is Benign according to our data. Variant chr16-46697501-T-C is described in ClinVar as Benign. ClinVar VariationId is 129866.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.055 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0186 (2831/152268) while in subpopulation NFE AF = 0.0258 (1752/68018). AF 95% confidence interval is 0.0248. There are 45 homozygotes in GnomAd4. There are 1396 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 45 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ORC6NM_014321.4 linkc.675T>C p.Asp225Asp synonymous_variant Exon 7 of 7 ENST00000219097.7 NP_055136.1
ORC6NR_037620.2 linkn.781T>C non_coding_transcript_exon_variant Exon 7 of 7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ORC6ENST00000219097.7 linkc.675T>C p.Asp225Asp synonymous_variant Exon 7 of 7 1 NM_014321.4 ENSP00000219097.2

Frequencies

GnomAD3 genomes
AF:
0.0186
AC:
2833
AN:
152150
Hom.:
45
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00471
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0201
Gnomad ASJ
AF:
0.0222
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.0390
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0258
Gnomad OTH
AF:
0.0215
GnomAD2 exomes
AF:
0.0186
AC:
4683
AN:
251270
AF XY:
0.0190
show subpopulations
Gnomad AFR exome
AF:
0.00302
Gnomad AMR exome
AF:
0.0113
Gnomad ASJ exome
AF:
0.0236
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0363
Gnomad NFE exome
AF:
0.0259
Gnomad OTH exome
AF:
0.0228
GnomAD4 exome
AF:
0.0241
AC:
35171
AN:
1461214
Hom.:
520
Cov.:
30
AF XY:
0.0238
AC XY:
17291
AN XY:
726926
show subpopulations
African (AFR)
AF:
0.00266
AC:
89
AN:
33472
American (AMR)
AF:
0.0122
AC:
546
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0218
AC:
570
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.00468
AC:
404
AN:
86244
European-Finnish (FIN)
AF:
0.0341
AC:
1819
AN:
53414
Middle Eastern (MID)
AF:
0.0201
AC:
116
AN:
5766
European-Non Finnish (NFE)
AF:
0.0273
AC:
30341
AN:
1111390
Other (OTH)
AF:
0.0213
AC:
1286
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1783
3566
5348
7131
8914
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1140
2280
3420
4560
5700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0186
AC:
2831
AN:
152268
Hom.:
45
Cov.:
33
AF XY:
0.0187
AC XY:
1396
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00470
AC:
195
AN:
41532
American (AMR)
AF:
0.0201
AC:
308
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0222
AC:
77
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00497
AC:
24
AN:
4826
European-Finnish (FIN)
AF:
0.0390
AC:
414
AN:
10608
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0258
AC:
1752
AN:
68018
Other (OTH)
AF:
0.0213
AC:
45
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
142
284
427
569
711
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0232
Hom.:
133
Bravo
AF:
0.0174
Asia WGS
AF:
0.00375
AC:
14
AN:
3478
EpiCase
AF:
0.0254
EpiControl
AF:
0.0244

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jan 17, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Meier-Gorlin syndrome 3 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
6.0
DANN
Benign
0.38
PhyloP100
-0.055
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34343511; hg19: chr16-46731413; COSMIC: COSV54624238; COSMIC: COSV54624238; API